Hong, C., Wang, D., Chen, Y., Lin, S., Huang, Y., Li, L., Chen, D., Lian, W. (2026). Real-world chemotherapy use and survival outcomes in postmenopausal HR+/HER2−breast cancer with low genomic risk (RS ≤ 25): a multicenter cohort study from China. Scientific Reports. https://doi.org/10.1038/s41598-026-51364-7